|Articles|January 20, 2020
Case Study to Demonstrate Sensitivity in Immunogenicity Assay Should be Based on Result of Both Screening and Confirmatory Tier
Author(s)Syngene
Mahesh Kumar shares background, insights, and results of a study in which a relevant sensitivity and low positive control value in immunogenicity assays are identified.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
EMA Calls New EU Pharma Legislation Most Significant in Two Decades
2
European Parliament Revamps Pharmaceutical Policy Framework
3
Indivumed, URMC Launch Joint Venture for Patient-Centric Cancer R&D
4
Optimizing Pharmaceutical Manufacturing Efficiency
5
